Amarin Corp Plcuk (AMRN) Long-Term Deferred Tax (2010 - 2017)
Amarin Corp Plcuk (AMRN) posted quarterly Long-Term Deferred Tax of $11.1 million for Q3 2017, down 51.83% YoY from $23.0 million in Q3 2016, and little changed sequentially from $11.1 million in Q2 2017.
Amarin Corp Plcuk (AMRN) Long-Term Deferred Tax (2010 - 2017) Analysis & Trends
Amarin Corp Plcuk has disclosed Long-Term Deferred Tax across 8 years of filings, most recently posting $11.1 million for Q3 2017.
- In Q3 2017, Long-Term Deferred Tax fell 51.83% year-over-year to $11.1 million; the TTM figure through Sep 2017 stood at $11.1 million (down 51.83% YoY), while the FY2016 annual figure was $11.1 million, down 44.23% from the prior year.
- Long-Term Deferred Tax held at $11.1 million in Q3 2017, from $11.1 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for AMRN reached as high as $23.0 million in Q3 2016 and fell as low as $11.1 million in Q4 2016.
- The 5-year median for Long-Term Deferred Tax is $12.6 million (2014), against an average of $14.1 million.
- Annual changes were most pronounced in 2016 — Long-Term Deferred Tax jumped 63.45% — and 2017, when it tumbled 51.83%.
- A 5-year view of Long-Term Deferred Tax shows it stood at $11.9 million in 2013, then advanced by 5.12% to $12.6 million in 2014, then jumped by 58.27% to $19.9 million in 2015, then sank by 44.23% to $11.1 million in 2016, then changed by 0.0% to $11.1 million in 2017.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $11.1 million, $11.1 million, and $11.1 million for Q3 2017, Q2 2017, and Q1 2017 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 11.08 Mn |
| Jun 30, 2017 | 11.08 Mn |
| Mar 31, 2017 | 11.08 Mn |
| Dec 31, 2016 | 11.08 Mn |
| Sep 30, 2016 | 23.01 Mn |
| Jun 30, 2016 | 21.72 Mn |
| Mar 31, 2016 | 18.68 Mn |
| Dec 31, 2015 | 19.87 Mn |
| Sep 30, 2015 | 14.14 Mn |
| Jun 30, 2015 | 13.29 Mn |
| Mar 31, 2015 | 12.65 Mn |
| Dec 31, 2014 | 12.56 Mn |
| Sep 30, 2014 | 11.86 Mn |
| Jun 30, 2014 | 11.94 Mn |
| Mar 31, 2014 | 11.97 Mn |
| Dec 31, 2013 | 11.94 Mn |
| Sep 30, 2013 | 14.43 Mn |
| Jun 30, 2013 | 12.88 Mn |
| Mar 31, 2013 | 11.99 Mn |
| Dec 31, 2012 | 8.04 Mn |